Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study
Maneno muhimu
Kikemikali
Tarehe
Imethibitishwa Mwisho: | 10/31/2017 |
Iliyowasilishwa Kwanza: | 10/31/2017 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 11/16/2017 |
Iliyotumwa Kwanza: | 11/19/2017 |
Sasisho la Mwisho Liliwasilishwa: | 11/16/2017 |
Sasisho la Mwisho Lilichapishwa: | 11/19/2017 |
Tarehe halisi ya kuanza kwa masomo: | 10/25/2015 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 07/31/2016 |
Tarehe ya Kukamilisha Utafiti: | 07/31/2016 |
Hali au ugonjwa
Uingiliaji / matibabu
Drug: Gum Arabic group
Drug: Chemotherapy
Behavioral: Lifestyle counseling
Awamu
Vikundi vya Arm
Mkono | Uingiliaji / matibabu |
---|---|
Experimental: Gum Arabic group Patients of study group was received a dose of 30 grams Gum Arabic per day as oral solution (dissolved in 250 ml purified water) for six weeks along with the chemotherapy prescribed addition to verbal instructions pertaining to the optimal nutrition and daily routine for oral hygiene. | Drug: Gum Arabic group Gum acacia, also known as Gum Arabic is exuded from acacia trees; mainly from Acacia Senegal (gum Hashab or Kordofan gum) which was used in this study. |
Other: Control group Patients of control group was received only chemotherapy regimen and verbal counseling pertaining to the optimal nutrition and daily routine for oral hygiene. |
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 14 Years Kwa 14 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - Patients whom well diagnosed with cancer in any stage were eligible for enrolment if chemotherapy is part of their treatment plan. Exclusion Criteria: Patients were excluded if - they had received recent previous chemotherapy or radiotherapy, - they had oral mucositis or periodontitis, - there is evidence of any systemic diseases. |
Matokeo
Hatua za Matokeo ya Msingi
1. The effect of Gum Arabic to prevent Chemotherapy-induced Oral Mucositis was the primary outcome that assessed using World Health Organization Mucositis Scoring. [Six weeks for each participant from starting therapy.]